These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38314653)

  • 21. Seeded fibrils of the germline variant of human λ-III immunoglobulin light chain FOR005 have a similar core as patient fibrils with reduced stability.
    Pradhan T; Annamalai K; Sarkar R; Huhn S; Hegenbart U; Schönland S; Fändrich M; Reif B
    J Biol Chem; 2020 Dec; 295(52):18474-18484. PubMed ID: 33093170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain.
    Davis DP; Gallo G; Vogen SM; Dul JL; Sciarretta KL; Kumar A; Raffen R; Stevens FJ; Argon Y
    J Mol Biol; 2001 Nov; 313(5):1021-34. PubMed ID: 11700059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incomplete Refolding of Antibody Light Chains to Non-Native, Protease-Sensitive Conformations Leads to Aggregation: A Mechanism of Amyloidogenesis in Patients?
    Morgan GJ; Usher GA; Kelly JW
    Biochemistry; 2017 Dec; 56(50):6597-6614. PubMed ID: 29200282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell Damage in Light Chain Amyloidosis: FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING.
    Marin-Argany M; Lin Y; Misra P; Williams A; Wall JS; Howell KG; Elsbernd LR; McClure M; Ramirez-Alvarado M
    J Biol Chem; 2016 Sep; 291(38):19813-25. PubMed ID: 27462073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and energetic basis of overrepresented λ light chain in systemic light chain amyloidosis patients.
    Zhao J; Zhang B; Zhu J; Nussinov R; Ma B
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2294-2303. PubMed ID: 29241665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of domain interactions in the aggregation of full-length immunoglobulin light chains.
    Rennella E; Morgan GJ; Kelly JW; Kay LE
    Proc Natl Acad Sci U S A; 2019 Jan; 116(3):854-863. PubMed ID: 30598439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A constant domain mutation in a patient-derived antibody light chain reveals principles of AL amyloidosis.
    Rottenaicher GJ; Absmeier RM; Meier L; Zacharias M; Buchner J
    Commun Biol; 2023 Feb; 6(1):209. PubMed ID: 36823438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic control in protein folding for light chain amyloidosis and the differential effects of somatic mutations.
    Blancas-Mejía LM; Tischer A; Thompson JR; Tai J; Wang L; Auton M; Ramirez-Alvarado M
    J Mol Biol; 2014 Jan; 426(2):347-61. PubMed ID: 24157440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.
    Marin-Argany M; Güell-Bosch J; Blancas-Mejía LM; Villegas S; Ramirez-Alvarado M
    Protein Sci; 2015 Nov; 24(11):1829-40. PubMed ID: 26300552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains.
    Morgan GJ; Kelly JW
    J Mol Biol; 2016 Oct; 428(21):4280-4297. PubMed ID: 27569045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
    Poshusta TL; Sikkink LA; Leung N; Clark RJ; Dispenzieri A; Ramirez-Alvarado M
    PLoS One; 2009; 4(4):e5169. PubMed ID: 19365555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Antibody Light-Chain Linker Regulates Domain Orientation and Amyloidogenicity.
    Weber B; Hora M; Kazman P; Göbl C; Camilloni C; Reif B; Buchner J
    J Mol Biol; 2018 Dec; 430(24):4925-4940. PubMed ID: 30414962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Protein Thermodynamics and Primary Structure in Fibrillogenesis of Variable Domains from Immunoglobulin Light Chains.
    Rennella E; Morgan GJ; Yan N; Kelly JW; Kay LE
    J Am Chem Soc; 2019 Aug; 141(34):13562-13571. PubMed ID: 31364359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing oligomerization of amyloid beta peptide in silico.
    Dorosh L; Stepanova M
    Mol Biosyst; 2016 Dec; 13(1):165-182. PubMed ID: 27844078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation.
    Mazzini G; Ricagno S; Caminito S; Rognoni P; Milani P; Nuvolone M; Basset M; Foli A; Russo R; Merlini G; Palladini G; Lavatelli F
    FEBS J; 2022 Jan; 289(2):494-506. PubMed ID: 34482629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic evidence for multiple aggregation pathways in antibody light chain variable domains.
    Wong S; West ME; Morgan GJ
    Protein Sci; 2024 Mar; 33(3):e4871. PubMed ID: 38100259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept.
    Ramirez-Alvarado M; Barnidge DR; Murray DL; Dispenzieri A; Marin-Argany M; Dick CJ; Cooper SA; Nasr SH; Ward CJ; Dasari S; Jiménez-Zepeda VH; Leung N
    Am J Hematol; 2017 Jun; 92(6):536-541. PubMed ID: 28295502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro aggregation behavior of a non-amyloidogenic λ light chain dimer deriving from U266 multiple myeloma cells.
    Arosio P; Owczarz M; Müller-Späth T; Rognoni P; Beeg M; Wu H; Salmona M; Morbidelli M
    PLoS One; 2012; 7(3):e33372. PubMed ID: 22432016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic protein structures in normal function and pathologic misfolding in systemic amyloidosis.
    Lewkowicz E; Gursky O
    Biophys Chem; 2022 Jan; 280():106699. PubMed ID: 34773861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrosine residues mediate fibril formation in a dynamic light chain dimer interface.
    DiCostanzo AC; Thompson JR; Peterson FC; Volkman BF; Ramirez-Alvarado M
    J Biol Chem; 2012 Aug; 287(33):27997-8006. PubMed ID: 22740699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.